Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
446.7 USD | +0.34% | +3.79% | +9.66% |
05-15 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
05-14 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.66% | 115B | |
+11.91% | 106B | |
-2.59% | 21.96B | |
-13.85% | 21.87B | |
-5.29% | 19.21B | |
-3.23% | 18.08B | |
-38.57% | 17.71B | |
+6.28% | 14.32B | |
+33.83% | 12.42B | |
-23.67% | 8.23B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Insider Sold Shares Worth $2,023,906, According to a Recent SEC Filing